Crescent Biopharma
CBIO
#6945
Rank
A$1.05 B
Marketcap
A$28.32
Share price
-2.01%
Change (1 day)
N/A
Change (1 year)

Revenue for Crescent Biopharma (CBIO)

Revenue in 2026 (TTM): A$17.69 Million

According to Crescent Biopharma's latest financial reports the company's current revenue (TTM ) is A$16.44 Million. In 2025 the company made a revenue of A$16.18 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Crescent Biopharma from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) A$17.69 M9.27%
2025 A$16.18 M